Skip to main content
. Author manuscript; available in PMC: 2018 Jul 24.
Published in final edited form as: Eur J Cancer Prev. 2017 Jul;26(4):357–364. doi: 10.1097/CEJ.0000000000000262

Table 2.

Population and sample sizes of the Jiangsu Four Cancers Study, 2003–2010

Four Study Sites in Jiangsu Province
Total population in 2010 Cancer cases reported in 2003–2010a
Esophageal cancer Stomach cancer Lung cancer Liver cancer

4,275,385 14,770 8,763 9,152 6,815

Jiangsu Four Cancers Study
Controls, N (%) Cases, N (%)
Esophageal cancer Stomach cancer Lung cancer Liver cancer

Questionnaire data collected 8,019 (100) 2,969 (100) 2,216 (100) 2,871 (100) 2,018 (100)
Proxy interviews 0 (0) 822 (27.7) 712 (32.1) 1,097 (38.2) 793 (39.3)
Blood samples collected 6,650 (82.9) 2,459 (82.8) 1,710 (77.2) 1,799 (62.7) 1,190 (59.0)
County of residence
    Dafeng 2,536 (31.6) 639 (21.5) 644 (29.1) 624 (21.7) 632 (31.3)
    Ganyu 2,010 (25.1) 931 (31.4) 570 (25.7) 799 (27.8) 390 (19.3)
    Chuzhou 1,180 (14.7) 968 (32.6) 470 (21.2) 514 (17.9) 303 (15.0)
    Tongshan 2,293 (28.6) 431 (14.5) 532 (24.0) 934 (32.5) 693 (34.3)
Method of cancer diagnosis
    Medical imagingb 639 (21.5) 422 (19.0) 2,065 (71.9) 1,593 (78.9)
    Pathology 1,240 (41.8) 1,035 (46.7) 508 (17.7) 237 (11.7)
    Endoscopy 898 (30.2) 644 (29.1) 89 (3.1) 12 (0.6)
    Biochemistryc 34 (1.1) 32 (1.4) 48 (1.7) 85 (4.2)
    Clinical diagnosis 158 (5.3) 83 (3.7) 161 (5.6) 91 (4.5)
a

Does not include the number of cases from Tongshan in 2003.

b

Includes computer tomography (CT), X-ray, ultrasound, and magnetic resonance imaging (MRI).

c

Includes biochemistry, immunology, cytology, and alpha-fetroprotein (AFP) tests.